Borosil Scientific BOROSCI
Laboratory glassware and instruments plus pharma primary packaging (Klasspack vials, ampoules and cartridges)
Mapped in 1 theme: Pharmaceuticals.
Where Borosil Scientific sits in the supply chain
Borosil Scientific appears in 1 supply-chain layer in one theme, Pharmaceuticals.
Pharmaceuticals › Packaging, glass & excipients
Direct supplierOther companies in this layer
Revenue and profit
| ₹ Cr | FY24 | FY25 | FY26 |
|---|---|---|---|
| Revenue | 392 | 434 | 462 |
| Net profit | 23 | 27 | 35 |
Latest-year revenue ₹462 Cr (FY26, company-wide). Wider screens show FY22 onwards.
Strengths
- Direct exposure to injectable and lab demand via Klasspack primary packaging
- Brand leadership in Indian lab glassware
Risks
- Very small company, and the stock has fallen in the year to Oct 2026
- Competes with SCHOTT Poonawalla and imports in pharma glass
Common questions
What does Borosil Scientific do?
Laboratory glassware and instruments plus pharma primary packaging (Klasspack vials, ampoules and cartridges).
Where does Borosil Scientific sit in the supply chain?
Borosil Scientific (NSE: BOROSCI) is mapped in 1 supply-chain layer: Packaging, glass & excipients (Pharmaceuticals).
Who are Borosil Scientific's peers?
In the Packaging, glass & excipients layer of Pharmaceuticals: Sigachi Industries, SCHOTT Poonawalla (not NSE-listed) and ACG Worldwide (not NSE-listed).
What is Borosil Scientific's market cap and valuation?
As of 30 Oct 2026: market cap ₹906 Cr, P/E 19.3x, ROCE 12.1%, ROE 9.5%, dividend yield 0%.